FDA Letter API

Armada Nutrition

Letter data

Company
Armada Nutrition
Recipient
Armada Nutrition | United States
Issue date
2018-03-13
Posted date
Not available
FDA office
United States
Subject
Not available
Product
Not available
CMS ID
Not available
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Armada Nutrition March 13, 2018 More Warning Letters Warning Letters About Warning and Close-Out Letters Recipient: Armada Nutrition United States Issuing Office: United States Cincinnati District Office 6751 Steger Drive Cincinnati, OH 45237 Telephone: (513) 679-2700 FAX: (513) 679-2772 VIA Email March 13, 2018 Mr. Brent A. Laffey, President Armada Nutrition, LLC 4637 Port Royal Rd. Spring Hill, TN 37174-2834 The Food and Drug Administration (FDA) has completed an evaluation of your firm 's corrective actions in response to our Warning Letter 523876 dated August 1, 2017. Based on our evaluation, it appears that you have addressed the violations and/or deviations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The FDA expects you and your firm to maintain compliance with current good manufacturing practices and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations and/or deviations be observed during a subsequent inspection or through other means. Sincerely, /S/ Stephen J. Rabe Compliance Officer Content current as of: 03/19/2018